Compounds > 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester
Page last updated: 2024-09-03

2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester and Cirrhosis

2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester has been researched along with Cirrhosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aihara, K; Fujii, S; Horinouchi, Y; Ikeda, Y; Imanishi, M; Ishizawa, K; Izawa-Ishizawa, Y; Kihira, Y; Minakuchi, K; Sakurada, T; Tamaki, T; Tominaga, E; Tomita, S; Tsuchiya, K; Tsuneishi, T1

Other Studies

1 other study(ies) available for 2,6-dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester and Cirrhosis

ArticleYear
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:1

    Topics: Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Calcium; Cell Movement; Cell Proliferation; Fibrosis; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Nifedipine; Nitroso Compounds; Oxidative Stress; Rats; Reactive Oxygen Species

2013